Stock CTXR CITIUS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Citius Pharmaceuticals, Inc.

Equities

CTXR

US17322U2078

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
0.7723 USD +3.55% Intraday chart for Citius Pharmaceuticals, Inc. +59.11% +2.09%
May. 21 Citius Pharmaceuticals, Inc. Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution CI
May. 14 Citius Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CITIUS PHARMACEUTICALS, INC.
Other Biotechnology & Medical Research
+3.55%+59.11%+2.09%-34.55%-27.40% 135M
Bullish
Neutral
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CTXR Stock
  4. Charts Citius Pharmaceuticals, Inc.
  5. Comparison Chart